Receptor tyrosine-protein kinase erbB-2 (48-56)

Receptor tyrosine-protein kinase erbB-2 (48-56) is a synthetic peptide fragment derived from the HER2/neu protein, a member of the epidermal growth factor receptor (EGFR) family. This peptide encompasses amino acid residues 48 to 56 of the erbB-2 sequence, a region of notable interest in molecular oncology and cell signaling research. As a defined peptide epitope, it serves as a valuable tool for investigating the structure-function relationships, signaling mechanisms, and immunological properties associated with the erbB-2 receptor, which is frequently overexpressed in various malignancies. The precise sequence and biochemical properties of this peptide enable researchers to dissect specific molecular interactions and to model cellular processes relevant to erbB-2 biology.

Epitope mapping: The 48-56 peptide fragment is widely utilized in epitope mapping studies aimed at identifying antibody binding sites within the HER2/neu protein. By employing this defined sequence, researchers can determine the specificity and affinity of monoclonal or polyclonal antibodies generated against erbB-2. Such studies are essential for characterizing immune recognition, optimizing antibody-based detection methods, and supporting the rational design of immunoreagents for analytical or diagnostic applications.

Signal transduction research: As a segment of the extracellular domain of the erbB-2 receptor, this peptide provides a functional probe for elucidating receptor-ligand interactions and downstream signaling pathways. It can serve as a competitive inhibitor or a molecular mimic in biochemical assays designed to explore the dynamics of receptor dimerization, phosphorylation events, or protein-protein interactions that govern cell growth and differentiation. These applications facilitate a deeper understanding of the molecular mechanisms underlying erbB-2-mediated signal transduction.

Peptide-based assay development: The erbB-2 (48-56) peptide is frequently incorporated into immunoassay platforms, such as enzyme-linked immunosorbent assays (ELISA) and peptide microarrays, for the detection and quantification of HER2/neu-specific antibodies or other interacting molecules. Its defined sequence and high specificity make it an ideal standard or capture reagent in assay development, supporting the advancement of sensitive and reproducible analytical tools for research laboratories.

T-cell epitope studies: This peptide serves as a model antigen in studies of T-cell recognition and activation. By presenting the 48-56 fragment in the context of major histocompatibility complex (MHC) molecules, researchers can investigate the cellular immune response to erbB-2-derived epitopes, characterize T-cell receptor specificity, and assess mechanisms of immune surveillance or tolerance. These experiments are fundamental to understanding the immunogenic landscape of tumor-associated antigens and guiding the development of peptide-based immunological assays.

Peptide synthesis and modification research: The erbB-2 (48-56) fragment is also valuable as a template for studies in peptide chemistry, including the synthesis of modified analogs, conjugates, or labeled derivatives. By introducing site-specific modifications, researchers can explore structure-activity relationships, enhance peptide stability, or develop novel molecular probes. Such work contributes to the broader field of peptide engineering and supports the creation of innovative research tools for molecular and cellular investigations.

1. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

2. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

3. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

4. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

5. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency